Late effects following HSCT for childhood ALL: A national single‐center study using three different modalities of delivery of total body irradiation
Pediatric Blood & Cancer · 2024
DOI: 10.1002/pbc.31163 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pediatric Blood & Cancer, 2024. Verfasst von Hilde Hylland Uhlving und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics and Adolescent Medicine, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark. Hauptthemen laut MEDLINE: Hematopoietic Stem Cell Transplantation, Whole-Body Irradiation, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Transplantation Conditioning. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
Total body irradiation (TBI) is a pivotal part of conditioning prior to hematopoietic stem cell transplantation (HSCT) for childhood acute lymphoblastic leukemia (ALL), yet evidence is sparse regarding the effect of TBI delivery techniques on acute and late toxicities.
Design
In a national cohort of pediatric HSCT‐recipients, we compared three TBI schedules; 12 Gray (Gy) delivered as (i) 4 Gy daily fractions from 2008 to 2011 ( n = 12); (ii) 2 Gy fractions twice daily with two‐dimensional (2D) planning technology from 2012 to 2015 ( n = 16); and (iii) 2 Gy twice daily with three‐dimensional (3D) planning intensity‐modulated radiotherapy (IMRT) from 2016 to 2020 ( n = 14).
Results
The 5‐year event‐free survival was 75.0%, 81.3%, and 81.3% in Cohorts 1, 2, and 3, respectively. Acute toxicity assessed as maximum ferritin and C‐reactive protein during the first 3 months post HSCT did not differ between cohorts, nor did the time to first hospital discharge (median 28, 32, and 31 days, p = .25). The incidences of acute graft‐versus‐host disease (GvHD) (66%, 56%, 71%) and chronic GvHD (25%, 31%, 14%) were comparable. Pulmonary function assessed by spirometry did not differ significantly. The 5‐year cataract‐free survival was 33.3%, 79%, and 100% in Cohorts 1, 2, and 3, respectively. We found a nonsignificant tendency toward more endocrinopathies in Cohort 1 compared to Cohorts 2 and 3.
Conclusion
The change of modality did not result in more relapses. More fractionation led to improvement with a lower incidence of cataract and a tendency toward fewer endocrinopathies. The effect of 3D‐planning‐IMRT technology requires further evaluation in larger studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pediatrics and Adolescent Medicine, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark.
- Department of Radiation Oncology, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark.
ORCID-Profile: Hilde Hylland Uhlving
Zitieren
APA
Uhlving, H. H., Specht, L., Masmas, T. N., Bernsdorf, M., & Ifversen, M. (2024). Late effects following HSCT for childhood ALL: A national single‐center study using three different modalities of delivery of total body irradiation. Pediatric Blood & Cancer. https://doi.org/10.1002/pbc.31163
Vancouver
Uhlving HH, Specht L, Masmas TN, Bernsdorf M, Ifversen M. Late effects following HSCT for childhood ALL: A national single‐center study using three different modalities of delivery of total body irradiation. Pediatric Blood & Cancer. 2024. doi:10.1002/pbc.31163
BibTeX
@article{Uhlving2024,
author = {Uhlving, Hilde Hylland and Specht, Lena and Masmas, Tania Nicole and Bernsdorf, Mogens and Ifversen, Marianne},
title = {Late effects following HSCT for childhood ALL: A national single‐center study using three different modalities of delivery of total body irradiation},
journal = {Pediatric Blood & Cancer},
year = {2024},
doi = {10.1002/pbc.31163}
}
EUVIMED